  Inhibiting a signalling pathway concerns controlling the cellular processes
of a cancer cell's viability, cell division, and death. Assay protocols created
to see if the molecular structures of the drugs being tested have the desired
inhibition qualities often show great variability across experiments, and it is
imperative to diminish the effects of such variability while inferences are
drawn. In this paper we propose the study of experimental data through the
lenses of a mathematical model depicting the inhibition mechanism and the
activation-inhibition dynamics. The method is exemplified through assay data
obtained from the study of inhibition of the CXCL12/CXCR4 activation axis for
the melanoma cells. To mitigate the effects of the variability of the data on
the cell viability measurement, the cell viability is theoretically constructed
as a function of time depending on several parameters. The values of these
parameters are estimated by using the experimental data. Deriving approximation
for the cell viability in a theoretically pre-determined form has the
advantages of (i) being less sensitive to data variability (ii) the estimated
values of the parameters are interpreted directly in the biological processes,
(iii) the amount of variability explained via the approximation validates the
quality of the model, (iv) with the data integrated into the model one can
derive a more complete view over the whole process. These advantages are
demonstrated in the step-by-step implementation of the outlined approach.
